TITLE

NICE turnaround on Alzheimer's

AUTHOR(S)
Baines, Emma
PUB. DATE
March 2005
SOURCE
GP: General Practitioner;3/18/2005, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article informs that National Institute for Clinical Excellence (NICE), UK government organisation, is expected to reverse its recommendation that cholinesterase inhibitors should not be given to Alzheimer's patients on the National Health Service (NHS), following criticism from a government minister. Earlier this month, NICE released the first draft of a technology appraisal, which recommended that donepezil, rivas-tigmine and galantamine should not be used in the treatment of mild to moderate Alzheimer's disease. It also recommended that memantine should not be used for the treatment of moderately severe to severe Alzheimer's, except as part of ongoing or new clinical studies.
ACCESSION #
16508483

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics